Cargando…
Lower fasting blood glucose in neurofibromatosis type 1
Studies indicate a lower occurrence of diabetes mellitus (DM) in patients with neurofibromatosis type 1 (NF1). Fasting blood glucose (FBG) level is the main criterion used to diagnose DM and glucose intolerance. Therefore, this study compared FBG level between adults with NF1 and non-NF1 controls. W...
Autores principales: | Martins, Aline Stangherlin, Jansen, Ann Kristine, Rodrigues, Luiz Oswaldo Carneiro, Matos, Camila Maria, Souza, Marcio Leandro Ribeiro, de Souza, Juliana Ferreira, Diniz, Maria de Fátima Haueisen Sander, Barreto, Sandhi Maria, Diniz, Leonardo Mauricio, de Rezende, Nilton Alves, Riccardi, Vincent Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703950/ https://www.ncbi.nlm.nih.gov/pubmed/26631381 http://dx.doi.org/10.1530/EC-15-0102 |
Ejemplares similares
-
Increased insulin sensitivity in individuals with neurofibromatosis type 1
por: Martins, Aline Stangherlin, et al.
Publicado: (2018) -
Establishing a blood fructosamine reference range for the Brazilian population based on data from ELSA – Brasil
por: Pedrosa, William, et al.
Publicado: (2018) -
Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA–Brasil study
por: Diniz, Maria de Fátima Haueisen Sander, et al.
Publicado: (2020) -
Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil
por: Santos, Laura Luiza Menezes, et al.
Publicado: (2022) -
Physical Activity and Lipid Profile in the
ELSA-Brasil Study
por: da Silva, Raquel Caroline, et al.
Publicado: (2016)